Rapid and Sensitive Determination of Udenafil in Plasma by LC-MS/MS for Intranasal Pharmacokinetic Study in Rats-Reference-Cited by-同舟云学术

Rapid and Sensitive Determination of Udenafil in Plasma by LC-MS/MS for Intranasal Pharmacokinetic Study in Rats

Published:2011 Issue:9 Volume:59 Page:1083-1088
ISSN:0009-2363
Container-title:Chemical and Pharmaceutical Bulletin
language:en
Short-container-title:CHEMICAL & PHARMACEUTICAL BULLETIN

Author:

Ku Wan-Sung¹,Cho Hyun-Jong¹,Yoon In-Soo¹,Kim Jeong Hoon²,Cha Bong-Jin²,Kim Jung Sun³,Kim Kyeong-Mi⁴,Kang Shin-Kwon⁴,Chung Suk-Jae¹,Shim Chang-Koo¹,Kim Dae-Duk¹

Affiliation:

1. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University

2. Dong-A Pharm. Co., Ltd.

3. Division of Health Science, Dongseo University

4. R&D Institute, LCKorea Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Drug Discovery,General Chemistry,General Medicine

Link

http://www.jstage.jst.go.jp/article/cpb/59/9/59_9_1083/_pdf

Reference13 articles.

1. Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159

2. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?

3. Pharmacokinetics of DA‐8159, a New Erectogenic, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First‐Pass Effects

4. Simultaneous determination of udenafil and its active metabolite, DA-8164, in human plasma and urine using ultra-performance liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study

5. Looking to the Future for Erectile Dysfunction Therapies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A validated LC-MS/MS assay for the quantification of phosphodiesterase-5 inhibitors in human plasma;Journal of Chromatography B;2021-08

2. Enhanced Bioavailability of Tadalafil after Intranasal Administration in Beagle Dogs;Pharmaceutics;2018-10-15

3. Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules;European Journal of Pharmaceutics and Biopharmaceutics;2014-09

4. A review of analytical methods for the determination of four new phosphodiesterase type 5 inhibitors in biological samples and pharmaceutical preparations;Brazilian Journal of Pharmaceutical Sciences;2013-03

5. ADMET considerations for phosphodiesterase-5 inhibitors;Expert Opinion on Drug Metabolism & Toxicology;2012-07-07